Remote

Director, Distribution and GPOs

AVEO Pharmaceuticals
United States
Nov 05, 2024
JOB SUMMARY: The Director, Distribution and GPOs is responsible for developing and executing strategic trade plans for assigned accounts to support the successful commercialization of AVEO's lead oncology pipeline agent, Fotivda (tivozanib). This role will serve as the primary contact between AVEO and designated trade and distribution partners. The Director, Distribution and GPOs, will lead all account initiatives and is responsible for achieving expected business objectives across the oncology portfolio of Aveo products. This role will collaborate with multiple stakeholders including sales, marketing, market access, medical affairs, HEOR, compliance/legal and finance to ensure successful commercialization of products within the oncology pipeline. PRINCIPAL DUTIES: Develop, define, and implement account strategy and objectives for the continued successful commercialization of Fotivda (tivozanib) and potential future product launches. Ensure strong business relationships with assigned accounts Execute action plans to compliantly maximize market access for Aveo products Collaborate with sales, marketing, finance, legal/compliance, medical affairs and market access to optimize strategic opportunities and initiatives Contribute effectively to pricing and contracting strategy development Effectively communicate account positioning with internal stakeholders regularly Continually assess the competitive landscape and adjust strategies and tactics accordingly Manage budgeted items and responsibilities for understanding of overall gross to net impact Monitor trends and potential coverage and reimbursement issues, existing and emerging government and payer policies, competitive pricing and contracting strategies, and potential barriers to provider and patient access. REQUIRED QUALIFICATIONS/EXPERIENCE (BASIC QUALIFICATIONS): Minimum of a bachelor's degree; advanced degree preferred 10+ years of progressive experience within sales, marketing, or managed markets roles in account management, formulary access, reimbursement, distribution, program development, contract negotiations and policy development At least 5 years of successful oncology account or sales management experience Previous new product launch experience in Oncology Strong knowledge of distributor channel and GPO services Fluently understand the business of oncology, distribution, discounting, contracting and reimbursement Experience and understanding of oral oncology product access channels Strong understanding of relevant health care laws, including anti-kickback statute and false claims act, to ensure compliant contracting Experience in contract strategy development Ability to negotiate effective contract positioning and decisions with assigned account. Self-motivated, assertive, and self-confident with the ability to act with urgency and passion Proven ability to work with high level of integrity, accuracy, and attention to detail Strong organizational skills to maintain a high level of productivity, innovation, and prioritizing to complete assignments on time and within budget Ability to make thoughtful, timely and meaningful decisions to take corresponding actions Resourceful, creative, enthusiastic, innovative and results oriented Flexible, adaptable, diplomatic, and able to effectively manage through ambiguity Entrepreneurial, enjoys working in a fast paced, small company environment Effective budget development and management skills; ability to collaborate cross functionally Strong interpersonal and teambuilding skills Willingness to travel and attend industry meetings as needed High proficiency with Microsoft Office, Excel, Powerpoint About AVEO AVEO is a commercial-stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer. AVEO currently markets FOTIVDA (tivozanib) in the U.S. for the treatment of adult patients with relapsed or refractory renal cell carcinoma (RCC) following two or more prior systemic therapies. AVEO continues to develop FOTIVDA in immuno-oncology combinations in RCC and other indications, and has several other investigational programs in clinical development. AVEO is committed to creating an environment of diversity, equity and inclusion to diversify representation within the Company. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, or status as a protected veteran.